Skip to main content

Closed

OVID: Ovid Therapeutics Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+44.4% / yr

Operating margin-670.2%

ROIC-22.6%

Financially safe

Stretched

Debt / equity0.01×

Interest coverage0.0×

Current ratio10.17×

Ovid Therapeutics Inc.

OVIDNASDAQ Global Select·USD·Closed

Ovid Therapeutics Inc.

OVIDNASDAQ·USD·Closed

$2.22

−6.33%

$2.22

−$0.15 (6.33%)

52W Range

66thpctl

Volume

0.72×avg

Mkt Cap

414.34MUSD

P/E

-6.4TTM

Div Yield

–ann

52W Range

66thpctl

Volume

0.72×avg

Market Cap

414.34MUSD

P/E Ratio

-6.4TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings